Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT05777681
NCT05777681RecruitingNot Applicable

Management of Aorto-iliac Infection With BioIntegral Surgical No-React® Bovine Pericardial Xenografts

Fondazione Policlinico Universitario Agostino Gemelli IRCCS1 site in 1 country30 target enrollmentStarted: October 1, 2022Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
30
Locations
1
Primary Endpoint
Early Mortality
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

Aortic infections (AIs), including aortic graft infections (AGI) as well as mycotic aortic aneurysms (MAA), are rare. The aim of this study is to present our experience with xenogeneic aortic and aortoiliac reconstructions using the BioIntegral Surgical No-React® bovine pericardial graft.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Aortic infection
  • •Mycotic Aneurysm
  • •Aortic Graft Infection

Exclusion Criteria

  • •Absence of signs of infection

Outcomes

Primary Outcomes

Early Mortality

Time Frame: 30 days

Mortality 30 days after the procedure

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Tshomba Yamume

Prof

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Study Sites (1)

Loading locations...

Similar Trials

Enrolling By Invitation
Not Applicable
Complex EVAR in Inflammatory and Infective Abdominal and Thoracoabdominal Aortic AneurysmsInflammatory Abdominal Aortic AneurysmAneurysm, InfectedAneurysm, MycoticThoracoabdominal Aortic AneurysmAbdominal Aortic Aneurysm
NCT06380595CEVARII220
Recruiting
Not Applicable
Treatment of infected aortic aneurysm or vascular graft infection with a rifampicin-bonded gelatin-sealed Dacron graftinfected aortic aneurysm, vascular graft infection
JPRN-UMIN000022379Kyoto Prefectural University of Medicine Cardiovascular Surgery10
Terminated
Not Applicable
Covered Endovascular Reconstruction of Aortic Bifurcation (CERAB) for Extensive Aortoiliac Occlusive DiseaseAorto-Iliac AtherosclerosisAortoiliac Obstruction
NCT03767686Rijnstate Hospital28
Completed
Not Applicable
Endovascular Treatment of Aorto-iliac Disease Using in Situ FenestrationPeripheral Artery DiseaseAbdominal Aortic Aneurysm
NCT04062734Assistance Publique - Hôpitaux de Paris30
Recruiting
Not Applicable
Study of the Aortic and Large Arterial Vessel InfectionsAortic Infections and InflammationsMycotic AneurysmArterial Infections and InflammationsProsthetic Infection
NCT05660733Central Hospital, Nancy, France500
Management of Aorto-iliac Infection With... | Clinical Trial